NGLY1 Deficiency: A Rare Genetic Disorder Unlocks Therapeutic Potential for Common Diseases
Abstract The enzyme catalysing the removal of N‐linked glycans from misfolded glycoproteins in the cytosol is an evolutionary well‐conserved glycanase called Peptide:N‐glycanase (PNGase; NGLY1 in humans). NGLY1 hydrolyses the amide bond between an Asn and the proximal N‐acetylglucosamine (GlcNAc) of the attached N‐glycan, thereby converting that ...
Simon Walber +2 more
wiley +1 more source
NGLY1 as an Emerging Critical Modulator for Neurodevelopment and Pathogenesis in the Brain. [PDF]
N-glycanase 1 (NGLY1) is a cytoplasmic glycoenzyme that removes N-linked glycans from misfolded glycoproteins. It plays an important role in the endoplasmic reticulum-associated degradation (ERAD) pathway in mammalian cells.
Zhang H, Xue H, Wang YC, Liu Y.
europepmc +2 more sources
The TG2/LRP1 Pathway for T Cell Activation by Post-Translationally Modified Antigens. [PDF]
ABSTRACT Post‐translational modifications (PTMs) can generate neo‐epitopes, modified peptides that evade immune tolerance and trigger immune responses. This review focuses on the TG2/LRP1 pathway as a new paradigm for coupling the formation of post‐translationally modified peptides with their effective presentation as T‐cell antigens by dendritic cells.
Sewa AS, Yang FC, Khosla C.
europepmc +2 more sources
Loss of N-Glycanase 1 Alters Transcriptional and Translational Regulation in K562 Cell Lines
N-Glycanase 1 (NGLY1) deficiency is an ultra-rare, complex and devastating neuromuscular disease. Patients display multi-organ symptoms including developmental delays, movement disorders, seizures, constipation and lack of tear production.
William F. Mueller +15 more
doaj +1 more source
NGLY1 Deficiency Affects Glycosaminoglycan Biosynthesis and Wnt Signaling Pathway in Mice [PDF]
Individuals affected by NGLY1 Deficiency cannot properly deglycosylate and recycle certain proteins. Even though less than 100 people worldwide have been diagnosed with this rare autosomal recessive condition, thousands are affected by similar ...
Batten, Amy
core +1 more source
N-Glycanase 1 Transcriptionally Regulates Aquaporins Independent of Its Enzymatic Activity
Summary: Patients with pathogenic mutations in NGLY1 cannot make tears and have global developmental delay and liver dysfunction. Traditionally, NGLY1 cleaves intact N-glycans from misfolded, retrotranslocated glycoproteins before proteasomal degradation.
Mitali A. Tambe +2 more
doaj +1 more source
Enns et al. claimed in previous work that NGLY1 deficiency is a novel autosomal recessive disorder of the ERAD pathway. We present here a formalization of that claim, stating that all things of class “NGLY1 deficiency” that are in the context of a thing ...
Núria Queralt-Rosinach
doaj +1 more source
Image1_Generation and characterization of NGLY1 patient-derived midbrain organoids.pdf
NGLY1 deficiency is an ultra-rare, autosomal recessive genetic disease caused by mutations in the NGLY1 gene encoding N-glycanase one that removes N-linked glycan.
Ivan Pavlinov (6866153) +11 more
core +1 more source
Image2_Generation and characterization of NGLY1 patient-derived midbrain organoids.pdf
NGLY1 deficiency is an ultra-rare, autosomal recessive genetic disease caused by mutations in the NGLY1 gene encoding N-glycanase one that removes N-linked glycan.
Ivan Pavlinov (6866153) +11 more
core +1 more source
Novel small-molecule modifiers rescue pathology associated with NGLY1 Deficiency in a Caenorhabditis elegans model [PDF]
Functional loss in clearing misfolded proteins is associated with several human diseases. A mutation in one such gene, NGLY1 results in a rare genetic disorder in humans.
Broussalian, Michael +1 more
core +1 more source

